Abstract Details

Title Real-World Assessment of Relapse Rates in Patients with Multiple Sclerosis Newly Initiating Subcutaneous Interferon β-1a vs Oral Disease-Modifying Drugs

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 178

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Chris M. Kozma PRESENTER	No disclosure on file
Frederick E. Munschauer III, MD, FAAN (FEMC)	Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
Amy L. Phillips, PharmD (EMD Serono)	Amy L. Phillips, PharmD has received personal compensation for serving as an employee of EMD Serono, Inc.

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��